We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
-3.72%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$220M
AUM Growth
+$45.2M
Cap. Flow
+$60.5M
Cap. Flow %
27.47%
Top 10 Hldgs %
97.15%
Holding
66
New
25
Increased
1
Reduced
4
Closed
24

Top Buys

Rank Stock Value
1
BBRE icon
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
+$54M
2
DOCS icon
Doximity
DOCS
+$43M
3
VIR icon
Vir Biotechnology
VIR
+$11.4M
4
DUOL icon
Duolingo
DUOL
+$7.07M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.57M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$51.5M
2
DNLI icon
Denali Therapeutics
DNLI
+$2.12M
3
AAPL icon
Apple
AAPL
+$1.74M
4
SOLY
Soliton, Inc.
SOLY
+$1.53M
5
AMZN icon
Amazon
AMZN
+$1.28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.4%
2 Healthcare 36.13%
3 Technology 5.25%
4 Industrials 0.17%
5 Energy 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBRE icon
1
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.2B
$96M 43.58%
864,000
+517,000
+149% +$54M
DOCS icon
2
Doximity
DOCS
$4.7B
$33.1M 15.02%
+659,891
New +$43M
EOCW.U
3
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$20M 9.09%
2,000,000
– –
TSHA icon
4
Taysha Gene Therapies
TSHA
$1.52B
$13.4M 6.07%
1,147,040
– –
VIR icon
5
Vir Biotechnology
VIR
$1.8B
$12.2M 5.53%
+290,736
New +$11.4M
CDAK
6
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$9.44M 4.29%
847,108
– –
IMTX icon
7
Immatics
IMTX
$1.27B
$9.37M 4.26%
697,431
– –
VT icon
8
Vanguard Total World Stock ETF
VT
$81.7B
$9.06M 4.11%
84,339
– –
TXN icon
9
Texas Instruments
TXN
$254B
$6.03M 2.74%
32,000
– –
DUOL icon
10
Duolingo
DUOL
$6.71B
$5.45M 2.47%
+51,361
New +$7.07M
IVV icon
11
iShares Core S&P 500 ETF
IVV
$848B
$1.62M 0.74%
+3,400
New +$1.57M
BOND icon
12
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
$1.51M 0.68%
+13,775
New +$1.51M
SYRE icon
13
Spyre Therapeutics
SYRE
$7.56B
$1.17M 0.53%
9,827
– –
PLXP
14
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$502K 0.23%
62,673
– –
ACA icon
15
Arcosa
ACA
$7.2B
$372K 0.17%
+7,063
New +$378K
SCHE icon
16
Schwab Emerging Markets Equity ETF
SCHE
$13B
$307K 0.14%
+10,350
New +$316K
TFFP
17
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$196K 0.09%
883
– –
LXRX icon
18
Lexicon Pharmaceuticals
LXRX
$796M
$141K 0.06%
35,714
– –
APEN
19
DELISTED
Apollo Endosurgery, Inc.
APEN
$132K 0.06%
15,601
– –
SPY icon
20
State Street SPDR S&P 500 ETF Trust
SPY
$796B
$101K 0.05%
+213
New +$97.8K
AAPL icon
21
Apple
AAPL
$4.98T
$50K 0.02%
279
-11,027
-98% -$1.74M
CVX icon
22
Chevron
CVX
$401B
$41K 0.02%
+350
New +$39.8K
BABA icon
23
Alibaba
BABA
$273B
$21K 0.01%
+180
New +$26.2K
IWF icon
24
iShares Russell 1000 Growth ETF
IWF
$129B
$21K 0.01%
276
-8
-3% -$593
AMZN icon
25
Amazon
AMZN
$2.69T
$10K ﹤0.01%
60
-7,500
-99% -$1.28M
1
2 3

Similar funds

HP
Hound Partners New York $863M AUM 11.22% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $863M AUM 3.58% 1-Year Est. Return
BWA
BlueSky Wealth Advisors New Bern, North Carolina $863M AUM 17.63% 1-Year Est. Return
NEAM
New England Asset Management Farmington, Connecticut $863M AUM 17.57% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
BM
Berman McAleer Timonium, Maryland $864M AUM 22.02% 1-Year Est. Return
DOA
D'Orazio & Associates Falls Church, Virginia $864M AUM 21.64% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $864M AUM 15.83% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q4 2021 Portfolio in Review

As of Q4 2021, University of Texas/Texas AM Investment Management Co (UTIMCO) held 66 positions worth $220M, up 26% from $175M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $60.5M of net new capital in Q4 2021, opening 25 new positions and adding to 1 existing holding. Its largest new stake was Doximity: 659,891 shares worth $33.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Apple, an estimated $1.74M trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q4 2021 buy was Doximity: 659,891 shares worth $33.1M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) added most to JPMorgan BetaBuilders MSCI US REIT ETF in Q4 2021, an estimated $54M increase.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q4 2021 reduction was Apple, cutting an estimated $1.74M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Illumina in Q4 2021, selling an estimated $51.5M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 97% of its $220M portfolio in Q4 2021.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 25 new positions and closed 24 in Q4 2021.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 26% quarter-over-quarter to $220M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2021, filed 15 Feb 2022.